Flizasertib
Flizasertib is a selective RIPK1 kinase inhibitor used in research to investigate necroptosis and inflammatory pathways. It has demonstrated therapeutic potential in preclinical models of autoimmune and neurodegenerative diseases, supporting both in vitro and in vivo experimental applications.
Product Specifications
CAS Number
2268739-68-8
Product Name Alternative
Icapamespib, Icapamespib 2HCl, Flizasertib, PUHZ 151, PU-HZ 151, PUHZ151, PU-HZ151, PU-HZ-151, PUHZ-151
Field of Research
Cell Biology, Protein Biochemistry, Signal Transduction
Purity
99.39% (May vary between batches)
Smiles
F[C@@H]1C=2N ([C@@H] (C1) C3=CC=CC=C3) N=C (C (=O) C4CC4) N2
Molecular Formula
C15H14FN3O
Molecular Weight
271.29
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
abx115194 100 µL
Rho Guanine Nucleotide Exchange Factor 10 (ARHGEF10) Antibody
Sign In for Pricing
View Details 
CD9-H5259-100ug 100 µg
Human CD19 (20-291) Protein, Fc Tag, low endotoxin
Sign In for Pricing
View Details